Clinical Trials Browser

Phase 1 × INDUSTRY × ocaratuzumab × Clear all

NCT00354926 2016-01-07

Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin

NCT01858181 2014-03-03

Phase I Study of Subcutaneous Ocaratuzumab in Patients With Previously Treated CD20+ B-Cell Malignancies

Phase 1 Unknown

Previously Treated CD20+ B-cell Malignancies